Trial Outcomes & Findings for Implant Placement With Simultaneous Gum Grafting (NCT NCT01431144)

NCT ID: NCT01431144

Last Updated: 2017-02-01

Results Overview

Soft tissue thickness at the facial osseous crest.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

27 participants

Primary outcome timeframe

1 year

Results posted on

2017-02-01

Participant Flow

27 patients were entered, 13 for the test allograft group and 14 for the positive control connective tissue autograft group

There were no exclusions prior to assignment or treatment.

Participant milestones

Participant milestones
Measure
Connective Tissue Allograft
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Connective Tissue Autograft
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Overall Study
STARTED
13
14
Overall Study
COMPLETED
11
14
Overall Study
NOT COMPLETED
2
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Connective Tissue Allograft
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Connective Tissue Autograft
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Overall Study
Implant mobility and removal
2
0

Baseline Characteristics

Implant Placement With Simultaneous Gum Grafting

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Connective Tissue Allograft
n=13 Participants
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Connective Tissue Autograft
n=14 Participants
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Total
n=27 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
10 Participants
n=5 Participants
9 Participants
n=7 Participants
19 Participants
n=5 Participants
Age, Categorical
>=65 years
3 Participants
n=5 Participants
5 Participants
n=7 Participants
8 Participants
n=5 Participants
Age, Continuous
46 years
STANDARD_DEVIATION 21 • n=5 Participants
57 years
STANDARD_DEVIATION 10 • n=7 Participants
52 years
STANDARD_DEVIATION 16 • n=5 Participants
Gender
Female
7 Participants
n=5 Participants
9 Participants
n=7 Participants
16 Participants
n=5 Participants
Gender
Male
6 Participants
n=5 Participants
5 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
United States
13 participants
n=5 Participants
14 participants
n=7 Participants
27 participants
n=5 Participants

PRIMARY outcome

Timeframe: 1 year

Soft tissue thickness at the facial osseous crest.

Outcome measures

Outcome measures
Measure
Connective Tissue Allograft
n=11 Participants
A connective tissue allograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Connective Tissue Autograft
n=14 Participants
A connective tissue autograft was placed simultaneously with dental implant placement and soft tissue thickness was measured at baseline and Time 4.
Soft Tissue Thickness Over the Implant
0.6 mm
Standard Deviation 1.2
0.4 mm
Standard Deviation 0.7

Adverse Events

Connective Tissue Allograft

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Connective Tissue Autograft

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Henry Greenwell, Principal Investigator

University of Louisville

Phone: 502-852-6928

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place